Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Lancet

• Publication date

  1997-09-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(97)05381-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group.

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Calcium-channel blockade and incidence of cancer in aged populations.

  1996cited by this paper
• Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice

  1996cited by this paper
• Shanghai trial of nifedipine in the elderly (STONE).

  1996cited by this paper
• Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

  1996cited by this paper
• Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial.

  1996cited by this paper
• Calcium antagonists: not appropriate as first line antihypertensive agents.

  1996cited by this paper
• Chinese contribution to trials on antihypertensive therapy

  1996cited by this paper
• The risk of myocardial infarction associated with antihypertensive drug therapies.

  1995cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Treatment of hypertension in the elderly

  1995cited by this paper
• Guidelines for the management of hypertension: the world Health organisation/International society of Hypertension View

  1995cited by this paper
• Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension.

  1994cited by this paper
• Pharmacological treatment of hypertension.

  1994cited by this paper
• 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting

  1993cited by this paper
• Implications for trials in progress of publication of positive results.

  1993cited by this paper
• 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.

  1993cited by this paper
• A meta-analysis of outcome trials in elderly hypertensives.

  1992cited by this paper
• Systolic hypertension in the elderly program (SHEP) and Swedish trial in old patients with hypertension (STOP). The promises and the potential problems.

  1992cited by this paper
• Morbidity and Mortality

  1992cited by this paper
• Some lessons from systolic hypertension in the elderly program (SHEP).

  1992cited by this paper
• THE LANCET

  1992cited by this paper
• Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

  1991cited by this paper
• Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization

  1991cited by this paper
• Isolated systolic hypertension in the elderly.

  1990cited by this paper
• Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

  1986cited by this paper
• Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification.

  1986cited by this paper
• Randomised trial of treatment of hypertension in elderly patients in primary care.

  1986cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• The pathogenetic role and treatment of elderly hypertension.

  1981cited by this paper
• Treatment of mild hypertension in the elderly: A study initiated and administered by the National Heart Foundation of Australia

  1981cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper
• The diagnosis of a vas praevium by amnioscopy.

  1968cited by this paper

• Monoterapia versus asociaciones fijas en el tratamiento inicial de la hipertensión arterial

  2026cites this paper
• The Effect of Chronotherapy on Clinical Outcomes in Hypertensive Patients: A Systematic Review and Meta‐Analysis Comparing Bedtime Versus Morning Dosing of Antihypertensive Drugs

  2026cites this paper
• Factors Associated with Treatment-Resistant Hypertension: Results of a prospective observational Study

  2025cites this paper
• Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults

  2025cites this paper
• Controversies in hypertension therapy: bedtime dosing or daytime dosing?

  2025cites this paper
• Optimizing systolic blood pressure targets for elderly hypertensive patients: a meta-analysis of mortality, cardiovascular outcomes, and adverse events

  2025cites this paper
• Efficacy and Safety of Low-Dose Triple Single Pill Combination Versus Standard Care in the Management of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis of Three Randomized Controlled Trials

  2025cites this paper
• The continuum of prevention and heart failure in cardiovascular medicine: A joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology

  2025cites this paper
• Hypertensive heart disease in older patients: considerations for clinical practice.

  2025cites this paper
• Development of the European Society of Hypertension guidelines for the management of arterial hypertension: comparison of the helpfulness of ESH 2013, 2018, and 2023 guidelines

  2025cites this paper
• Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision).

  2025cites this paper
• Maximizing blood pressure lowering effects: a review of drug class comparisons and rationale for combination approaches

  2025cites this paper
• Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders.

  2025cites this paper
• Pharmacotherapy for hypertension in adults 60 years or older.

  2025cites this paper
• The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology.

  2025cites this paper
• The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes Trial.

  2025cites this paper
• Narrative review: Isolated nocturnal hypertension - A frosted glass.

  2025cites this paper
• Blood pressure targets, medication consideration and special concerns in elderly hypertension part I: General principles and special considerations.

  2024cites this paper
• Advancements in Ischemic Stroke Management: Transition from Traditional to Nanotechnological Approaches

  2024cites this paper
• Random forest model used to predict the medical out-of-pocket costs of hypertensive patients

  2024cites this paper
• Evening versus morning dosing regimen drug therapy for hypertension.

  2024cites this paper
• 2023 Guideline for the management of hypertension in the elderly population in China.

  2024cites this paper
• Intensive blood pressure control in isolated systolic hypertension: a post hoc analysis of a cluster randomized trial

  2024influential citation
• Hypertension and orthostatic hypotension in the elderly: a challenging balance

  2024cites this paper
• General Principles, Etiologies, Evaluation, and Management in Older Adults.

  2024cites this paper
• Placebo Effect: The Stem of Seminal Studies with Active Treatment Neurobiological Mechanisms, And Implications for Parkinson’s Disease with Deep Brain Stimulation

  2024cites this paper
• The Efficacy of Antihypertensive Drugs in Lowering Blood Pressure and Cardiovascular Events in the Elderly Population: A Systematic Review and Meta-Analysis

  2024cites this paper
• Current practice toward the use of antihypertensive agents in the management of hypertension – A cross-sectional study among Indian physicians

  2023cites this paper
• Pressure Building Against the Clock: The Impact of Circadian Misalignment on Blood Pressure

  2023cites this paper
• Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.

  2023cites this paper
• Deprescribing Antihypertensive Medications in Older People: A Narrative Review, Part 1.

  2023cites this paper
• Association between Low Blood Pressure and Subsequent Risk of Parkinson’s Disease in Older Adults Aged ≥75 Years

  2023cites this paper
• Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials

  2023cites this paper
• Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review

  2023cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis.

  2023cites this paper
• Amlodipine-a third generation dihydropyridine calcium antagonist

  2023cites this paper
• First-line diuretics versus other classes of antihypertensive drugs for hypertension.

  2023cites this paper
• Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study

  2023cites this paper
• Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.

  2023cites this paper
• Monitoring risk and preventing ischemic stroke in the very old

  2023cites this paper
• Calcium channel blockers for hypertension: old, but still useful

  2023cites this paper
• Body Position and Orthostatic Hypotension in Hypertensive Adults: Results from the Syst-Eur Trial

  2023cites this paper
• Effect of antihypertensive agents on the clinical outcome of hospitalized COVID-19 patients concomitant with hypertension: A systematic review and meta-analysis.

  2023cites this paper
• Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension

  2023cites this paper
• Polypill Therapy for Cardiovascular Disease Prevention and Combination Medication Therapy for Hypertension Management

  2023cites this paper
• Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?

  2023cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study

  2022cites this paper
• Medication regimen complexity and its association with adherence and blood pressure control among hypertensive patients at selected hospitals of South Gondar Zone: A hospital based cross sectional study

  2022cites this paper
• Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension

  2022cites this paper
• Prevalence and correlates of use of digital technology for managing hypertension among older adults

  2022cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2022cites this paper
• Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials

  2022cites this paper
• Time to benefit for stroke reduction after blood pressure treatment in older adults: A meta‐analysis

  2022cites this paper
• Update in Hypertension.

  2022cites this paper
• A fluid-structure interaction model accounting arterial vessels as a key part of the blood-flow engine for the analysis of cardiovascular diseases

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Risk Factors and Prevention

  2022cites this paper
• The impact of treatment of periodic limb movements in sleep on blood pressure in patients with and without sleep apnea

  2022cites this paper
• Trends in Blood Pressure Treatment Intensification in Older Adults With Hypertension in the United States, 2008 to 2018

  2022cites this paper
• Improving outcomes for older hypertensive patients: is more intensive treatment better?

  2022cites this paper
• Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat

  2022cites this paper
• Molecular mechanisms underlying some major common risk factors of stroke

  2022cites this paper
• Design and Implementation of the Modern Men’s Health Center: A Multidisciplinary Approach

  2021cites this paper
• Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT

  2021cites this paper
• Kidney and hypertension in older adults

  2021cites this paper
• Neurologic Complications of Hypertension

  2021cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2021cites this paper
• Chronoterapia hypertenzie: večerná aplikácia antihypertenzív ako reálny determinant kardiovaskulárnej prognózy?

  2021cites this paper
• Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study.

  2021cites this paper
• Prise en charge de l’hypertension artérielle en prévention cardiovasculaire primaire chez les personnes âgées et très âgées

  2021cites this paper
• How We Got Where We Are in Blood Pressure Targets

  2021cites this paper
• YUNPING GUO ALL RIGHTS RESERVED PREDICTIVE MODELING OF ISOLATED SYSTOLIC HYPERTENSION FROM CHANGES IN ARTERIAL COMPLIANCE AND PERIPHERAL RESISTANCE

  2021cites this paper
• Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.

  2021cites this paper
• Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.

  2021cites this paper
• Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.

  2021cites this paper
• Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature

  2021cites this paper
• Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications

  2021cites this paper
• Angiotensin-Converting Enzyme Inhibitor Induced Cough in Chinese Patients: a Systematic Review and Meta-analysis.

  2021cites this paper
• Characteristics and variation of fecal bacterial communities and functions in isolated systolic and diastolic hypertensive patients

  2021cites this paper
• Frequency of Refractory Hypertension in Turkish Patients and Evaluation of the Factors Affecting Refractory Hypertension

  2021cites this paper
• Heart Failure Primary Prevention: What Does SPRINT Add?

  2021cites this paper
• Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

  2021cites this paper
• Kidney and hypertension in older adults.

  2021cites this paper
• Pharmacotherapy for hypertension-induced left ventricular hypertrophy.

  2021cites this paper
• STUDY OF LIPID AND THYROID PROFILE IN EARLY MENOPAUSAL WOMEN IN DR. B.R.AMBEDKAR MEDICAL COLLEGE AND HOSPITAL.

  2021cites this paper
• Neurological complications of systemic hypertension.

  2021cites this paper
• Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database

  2021cites this paper
• KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.

  2021cites this paper
• How Should We Measure and Deal with Office Blood Pressure in 2021?

  2021cites this paper
• Starting Antihypertensive Drug Treatment With Combination Therapy

  2021cites this paper
• Stage A Heart Failure: Modern Strategies for an Effective Prevention.

  2021cites this paper
• Physician perceived barriers and facilitators for self-measured blood pressure monitoring- a qualitative study

  2021cites this paper
• Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials.

  2021cites this paper
• Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker

  2021cites this paper
• Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis

  2021cites this paper
• The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review

  2021cites this paper
• Effectiveness of home visiting on patients with hypertension

  2021cites this paper
• Biomarkers in essential hypertension

  2020cites this paper